The Germany Federal Ministry of Health’s Paul-Ehrlich-Institut (PEI) has approved Emergent BioSolutions’ (EBS -1.4%) large-scale Lansing, MI-based manufacturing site, Building 55, that will make its anthrax vaccine BioThrax. The approval allows product made there to be marketed in Germany, the only anthrax vaccine so licensed.
{iframe}http://seekingalpha.com/news/3238386-german-regulator-oks-emergent-bios-large-scale-biothrax-manufacturing-facility-well?utoken=77cea408193abfd0b8876d8484dacaab#email_link{/iframe}